...
首页> 外文期刊>Infection >Successful Long-Term Treatment with Linezolid for Disseminated Infection with Multiresistant Nocardia farcinica
【24h】

Successful Long-Term Treatment with Linezolid for Disseminated Infection with Multiresistant Nocardia farcinica

机译:用利奈唑胺成功长期治疗多重耐药诺卡氏性诺卡氏菌的传播感染

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Nocardiosis is a common infection in organ transplant recipients and other immunosuppressed patients, caused by different Nocardia species. Nocardia farcinica is one of the most predominant Nocardia species isolated in these patients, frequently presenting resistance to multiple antibiotics used as first-line agents [1, 2]. Linezolid is an oxazolidinone agent apparently well designed for treating chronic osteomyelitis, but data on its effectiveness and tolerability in patients on prolonged therapy with linezolid are limited.The authors present the case of an immunosuppressed patient who developed disseminated nocardiosis caused by a multiresistant N. farcinica strain requiring long-term treatment with linezolid.
机译:诺卡氏病是器官移植受者和其他免疫抑制患者的常见感染,由不同的诺卡氏菌引起。诺卡氏菌诺卡氏菌是这些患者中最主要的诺卡氏菌之一,经常对用作一线药物的多种抗生素具有耐药性[1、2]。利奈唑胺是恶唑烷酮类药物,显然设计用于治疗慢性骨髓炎,但在长期使用利奈唑胺治疗的患者中其有效性和耐受性方面的数据有限。需要长期用利奈唑胺治疗的菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号